Process Industries · Chemicals: Specialty · NSE: ROSSARI · data 2026-10-09

Rossari Biotech Ltd

Health check: Average (5.5/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹409.8

Market cap

₹2,268 cr

P/E

15.1

P/B

—

ROE

11.8%

ROCE

13.6%

Debt / equity

0.33

Dividend yield

0.12%

1-year return

-38.4%

52-week high

₹690.3

52-week low

₹375

Operating margin

8.3%

Growth

Revenue (last 12 months)	₹2,550 cr
Net profit (last 12 months)	₹151 cr
Sales growth, 3 years (yearly)	13.1%
Profit growth, 3 years (yearly)	11.6%

Similar companies

NOCIL Limited (NOCIL) · JG Chemicals Limited (JGCHEM) · India Glycols Limited (INDIAGLYCO) · Fischer Medical Ventures Ltd (FISCHER) · S H Kelkar and Company Ltd (SHK)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ROSSARI in NSE Scanner →